当前位置:首页 - 行情中心 - 千金药业(600479) - 财务分析 - 现金流量表

千金药业

(600479)

  

流通市值:48.63亿  总市值:57.19亿
流通股本:4.19亿   总股本:4.92亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,969,148,257.55898,339,610.323,668,781,157.52,753,669,163.26
  收到其他与经营活动有关的现金59,861,645.637,149,514.61190,753,093.32165,321,087.95
  经营活动现金流入小计2,029,009,903.15935,489,124.933,859,534,250.822,918,990,251.21
  购买商品、接受劳务支付的现金899,179,936.64372,003,991.311,484,097,006.611,151,404,589.69
  支付给职工以及为职工支付的现金431,072,705.21275,878,398.43727,461,455.98561,837,345.02
  支付的各项税费194,887,796.9485,631,938.26330,145,692.36244,635,935.85
  支付其他与经营活动有关的现金450,803,625.98303,628,360.43837,585,128.5718,144,004.75
  经营活动现金流出小计1,975,944,064.771,037,142,688.433,379,289,283.452,676,021,875.31
  经营活动产生的现金流量净额53,065,838.38-101,653,563.5480,244,967.37242,968,375.9
二、投资活动产生的现金流量:
  收回投资收到的现金63,545,542.4130,011,818.634,687,8792,400,000
  取得投资收益收到的现金81,900-4,566,896.21,513,950
  处置固定资产、无形资产和其他长期资产收回的现金净额10,035-2,218,068.19205,500
  投资活动现金流入小计63,637,477.4130,011,818.6311,472,843.394,119,450
  购建固定资产、无形资产和其他长期资产支付的现金32,098,111.3323,081,486.44124,167,277.1959,847,063.8
  投资支付的现金--818,306,060.02803,000,000
  投资活动现金流出小计32,098,111.3323,081,486.44942,473,337.21862,847,063.8
  投资活动产生的现金流量净额31,539,366.086,930,332.19-931,000,493.82-858,727,613.8
三、筹资活动产生的现金流量:
  吸收投资收到的现金--2,000,000-
  收到其他与筹资活动有关的现金119,455,205.99-132,522,366.255,594,632.23
  筹资活动现金流入平衡项目0-00
  筹资活动现金流入小计119,455,205.99-134,522,366.255,594,632.23
  偿还债务支付的现金--7,000,0003,000,000
  分配股利、利润或偿付利息支付的现金198,907,121.562,560165,449,386.97155,983,451.81
  其中:子公司支付给少数股东的股利、利润11,858,3002,56012,770,4005,080,000
  支付其他与筹资活动有关的现金34,905,915.82-111,069,011.9816,585,920
  筹资活动现金流出小计233,813,037.382,560283,518,398.95175,569,371.81
  筹资活动产生的现金流量净额-114,357,831.39-2,560-148,996,032.7-169,974,739.58
五、现金及现金等价物净增加额-29,752,626.93-94,725,791.31-599,751,559.15-785,733,977.48
  加:期初现金及现金等价物余额736,043,191.35736,043,191.351,335,794,750.51,335,794,750.5
  期末现金及现金等价物余额706,290,564.42641,317,400.04736,043,191.35550,060,773.02
补充资料:
  净利润199,899,671.27-375,670,800.76-
  资产减值准备27,178.14-4,067,560.71-
  固定资产和投资性房地产折旧34,146,861.87-59,220,152.9-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧34,146,861.87-59,220,152.9-
  无形资产摊销11,685,594.62-19,180,623.31-
  长期待摊费用摊销5,701,977.85-16,031,528.98-
  处置固定资产、无形资产和其他长期资产的损失-706,539.26--1,875,639.98-
  固定资产报废损失981,746.42-597,551.7-
  公允价值变动损失864,129.02--2,407,585.49-
  财务费用745,067.28-2,028,322.05-
  投资损失-13,658,049.61--44,191,162.06-
  递延所得税-1,804,863.94-98,211.45-
  其中:递延所得税资产减少-2,084,688.28--5,918,450.21-
    递延所得税负债增加279,824.34-6,016,661.66-
  存货的减少-784,399.62--8,469,772.27-
  经营性应收项目的减少-183,504,475.58--180,777,765.26-
  经营性应付项目的增加-17,613,180.21-244,398,674.81-
  其他---35,421,767.33-
  现金的期末余额706,290,564.42-736,043,191.35-
  减:现金的期初余额736,043,191.35-1,335,794,750.5-
  现金及现金等价物的净增加额-29,752,626.93--599,751,559.15-
公告日期2026-08-262026-04-292026-04-292025-10-30
审计意见(境内)标准无保留意见
TOP↑